Showing 980 – 990 of 1157 results
-
Blend Labs Inc Initiation
William Blair initiated research coverage of Blend Labs, Inc. (BLND $18.45). Blend provides a cloud-based software platform designed to power end-to-end journeys for consumer banking products, including mortgages, consumer loans, and deposit accounts.
-
AAON Inc Initiation
William Blair initiated research coverage of AAON, Inc. (AAON $89.90), a manufacturer of semi-custom and custom commercial HVAC systems.
-
Couchbase Inc Initiation
William Blair initiated research coverage of Couchbase, Inc. (BASE $31.30). Couchbase provides a NoSQL database (DB) platform for enterprises globally.
-
Ryan Specialty Holdings Group Inc Initiation
William Blair initiated research coverage of Ryan Specialty Holdings Group, Inc. (RYAN $29.74). Ryan Specialty Group provides distribution, underwriting, and product development services to retail insurance brokers and insurance carriers as a wholesale insurance broker and a managing underwriter.
-
Snap One Holdings Corp Initiation
William Blair initiated research coverage of Snap One Holdings Corp. (SNPO $17.55), a leading vertically integrated supplier in the professionally installed connected home market.
-
MaxCyte Inc Initiation
William Blair initiated research coverage of MaxCyte, Inc. (MXCT $14.34), a market-leading provider of enabling technologies for cell engineering. The company’s ExPERT platform is used to advance the discovery, development, and commercialization of next-generation cell therapies.
-
Icosavax Inc Initiation
William Blair initiated research coverage of Icosavax, Inc. (ICVX $34.09). Icosavax is a clinical-stage biotechnology company that uses its proprietary in silico designed virus-like particle (VLP) platform to develop vaccines for viral respiratory pathogens such as RSV and hMPV. In addition, Icosavax is exploring both booster and Beta-specific COVID-19 vaccine candidates.
-
AppLovin Corp Initiation
William Blair initiated research coverage of AppLovin Corp. (APP $56.93). AppLovin is a global technology company that provides advanced tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their apps.
-
agilon health inc Initiation
William Blair initiated research coverage of agilon health, inc. (AGL $33.49), a technology-enabled care management partner that works with independent primary care physician (PCP) groups to enable their transformation to risk-based care models.
-
Telix Pharmaceuticals Limited
William Blair initiated research coverage of Telix Pharmaceuticals Limited (TLX-ASX AUD 19.22), a commercial-stage radiopharmaceuticals company that markets Illuccix for imaging prostate cancer and may, pending regulatory approval, also market imaging agents for renal masses and glioblastoma.